SCHEMBL3810013

SCHEMBL3810013

CC(N)C(=O)NC(Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 3/20 0.37
ACE P12821 3/20 0.37
MME P08473 1/20 0.36
CPA1 P15085 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
NOD1 Q9Y239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9665720 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
SCHEMBL3916119 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
SCHEMBL3916112 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
SCHEMBL17293240 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
SCHEMBL749822 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
SCHEMBL749821 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
SCHEMBL29511173 1.00 CTRB1 (0.37) CTRB1ACEMMECPA1ACE2
Water SCHEMBL29655463 0.99 CTRB1 (0.36) CTRB1ACEMMECPA1ACE2
SCHEMBL4587799 0.99 CTRB1 (0.36) CTRB1ACEMMECPA1ACE2
SCHEMBL2813159 0.99 CTRB1 (0.36) CTRB1ACEMMECPA1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281340-B2 Method of producing N-acyl-amino group-containing compound AJINOMOTO CO., INC. (JP) 2025-04-22 US claimed
CN-119224161-A Method for detecting various dipeptides in rumen fluid of ruminant 中国科学院亚热带农业生态研究所 2024-12-31 CN claimed
US-20210071214-A1 METHOD OF PRODUCING N-ACYL-AMINO GROUP-CONTAINING COMPOUND AJINOMOTO CO., INC. (JP) 2021-03-11 US claimed
EP-3778912-A1 METHOD FOR PRODUCING N-ACYL-AMINO GROUP-CONTAINING COMPOUND AJINOMOTO CO., INC. (JP) 2021-02-17 EP claimed
CN-106573895-B Novel 5-acylsulfanyl-histidine compounds as precursors for the corresponding 5-sulfanylhistidines and disulfides thereof 特瑞海德公司 2020-11-24 CN claimed
WO-2019198367-A1 METHOD FOR PRODUCING N-ACYL-AMINO GROUP-CONTAINING COMPOUND 味の素株式会社 2019-10-17 WO claimed
CN-106573895-A Novel 5-acylsulfanyl-histidine compounds as precursors for the corresponding 5-sulfanylhistidines and disulfides thereof 特瑞海德公司 2017-04-19 CN claimed
EP-3148973-A1 NOVEL COMPOUNDS OF THE 5-ACYLSULFANYL-HISTIDINE TYPE AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THE DISULFIDES THEREOF Tetrahedron (FR) 2017-04-05 EP claimed
WO-2015181507-A1 NOVEL COMPOUNDS OF THE 5-ACYLSULFANYL-HISTIDINE TYPE AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THE DISULFIDES THEREOF TETRAHEDRON (FR) 2015-12-03 WO claimed
EP-1176154-B1 Carnosine derivatives, a process for the preparation thereof and pharmaceutical compositions containing them UNIV CATANIA (IT) 2005-06-29 EP claimed
EP-1176154-A1 Carnosine derivatives, a process for the preparation thereof and pharmaceutical compositions containing them Universita' Degli Studi Di Catania (IT) 2002-01-30 EP claimed
CN-1166963-A Composition containing zinc compound and p-acetaminophenyl acetic acid XIA XIAOLIN (CN) 1997-12-10 CN claimed
CN-1166320-A Composite of zinc containing compound and glutamines XIA XIAOLIN (CN) 1997-12-03 CN claimed
WO-2026089754-A1 COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES Finitus, LLC (US) 2026-04-30 WO disclosed
WO-2026089752-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES Finitus, LLC (US) 2026-04-30 WO disclosed
US-20260108583-A1 COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES FINITUS LLC (US) 2026-04-23 US disclosed
US-5374551-A Measurement of metabolism of alpha-methyl glucoside BIOLOG, INC. (US) 1994-12-20 US disclosed
EP-0132392-B1 ASYMMETRIC SYNTHESIS OF ALPHA-SUBSTITUTED-ALPHA-CYANOMETHYL ALCOHOLS ICI AUSTRALIA LIMITED (AU) 1992-01-02 EP disclosed
EP-0304954-A2 Cyclic dipeptide enantiomers ICI AUSTRALIA LIMITED (AU) 1989-03-01 EP disclosed
EP-0132392-A2 Asymmetric synthesis of alpha-substituted-alpha-cyanomethyl alcohols ICI AUSTRALIA LIMITED (AU) 1985-01-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108583-A1 COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES MUC1, VIP, LGALS4 CTRB1 216/4885ACE 732/4885MME 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.